NO20091122L - Benzo[1,2,3]tiadiazinderivater - Google Patents
Benzo[1,2,3]tiadiazinderivaterInfo
- Publication number
- NO20091122L NO20091122L NO20091122A NO20091122A NO20091122L NO 20091122 L NO20091122 L NO 20091122L NO 20091122 A NO20091122 A NO 20091122A NO 20091122 A NO20091122 A NO 20091122A NO 20091122 L NO20091122 L NO 20091122L
- Authority
- NO
- Norway
- Prior art keywords
- benzo
- tiadiazinderivater
- thiadiazine
- general formula
- dioxide derivatives
- Prior art date
Links
- 125000005605 benzo group Chemical group 0.000 title 1
- UOCUSOBVEHOMMB-UHFFFAOYSA-N 2h-1$l^{6},2,3-benzothiadiazine 1,1-dioxide Chemical class C1=CC=C2S(=O)(=O)NN=CC2=C1 UOCUSOBVEHOMMB-UHFFFAOYSA-N 0.000 abstract 2
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Det beskrives nye benzo[l,2,3]tiadiazin-l,l-dioksidderivater med den generelle formel (I), medikamenter inneholdende slike forbindelser samt anvendelsen av disse i farmasien. Benzo[l,2,3]tiadiazin-l,l-dioksidderivater med den generelle formel (I) er egnet for prevensjon eller terapi av sykdommer i sentralnervesystemet.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0600650A HU0600650D0 (en) | 2006-08-16 | 2006-08-16 | Benzo[1,2,3]thiadiazine-1,1-dioxide derivatives, process for their preparation, pharmaceutical compositions containing the same and their use |
| HU0700504A HU230720B1 (hu) | 2007-08-02 | 2007-08-02 | Benzo[1,2,3]tiadiazin-1,1-dioxid-származékok, eljárás előállításukra, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk |
| PCT/HU2007/000071 WO2008020255A1 (en) | 2006-08-16 | 2007-08-13 | Benzo[1,2,3]thiadiazine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091122L true NO20091122L (no) | 2009-05-06 |
Family
ID=89987666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091122A NO20091122L (no) | 2006-08-16 | 2009-03-13 | Benzo[1,2,3]tiadiazinderivater |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100168087A1 (no) |
| EP (1) | EP2061777A1 (no) |
| KR (1) | KR20090042959A (no) |
| AU (1) | AU2007285499A1 (no) |
| CA (1) | CA2661082A1 (no) |
| EA (1) | EA200900313A1 (no) |
| IL (1) | IL197067A0 (no) |
| NO (1) | NO20091122L (no) |
| WO (1) | WO2008020255A1 (no) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3153614A (en) * | 1961-03-16 | 1964-10-20 | Colgate Palmolive Co | 4-hydrazino-1, 2, 3-benzothiadiazine-1, 1-dioxide compositions and therapy |
| US3407198A (en) * | 1966-08-10 | 1968-10-22 | Upjohn Co | 2h-1, 2, 3-benzothiadiazine-1, 1-dioxides |
| JPS4994832A (no) * | 1973-01-26 | 1974-09-09 |
-
2007
- 2007-08-13 WO PCT/HU2007/000071 patent/WO2008020255A1/en not_active Ceased
- 2007-08-13 CA CA002661082A patent/CA2661082A1/en not_active Abandoned
- 2007-08-13 EA EA200900313A patent/EA200900313A1/ru unknown
- 2007-08-13 AU AU2007285499A patent/AU2007285499A1/en not_active Abandoned
- 2007-08-13 KR KR1020097005047A patent/KR20090042959A/ko not_active Withdrawn
- 2007-08-13 EP EP07804514A patent/EP2061777A1/en not_active Withdrawn
- 2007-08-13 US US12/377,771 patent/US20100168087A1/en not_active Abandoned
-
2009
- 2009-02-16 IL IL197067A patent/IL197067A0/en unknown
- 2009-03-13 NO NO20091122A patent/NO20091122L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090042959A (ko) | 2009-05-04 |
| EA200900313A1 (ru) | 2009-08-28 |
| EP2061777A1 (en) | 2009-05-27 |
| CA2661082A1 (en) | 2008-02-21 |
| AU2007285499A1 (en) | 2008-02-21 |
| WO2008020255A1 (en) | 2008-02-21 |
| IL197067A0 (en) | 2009-11-18 |
| US20100168087A1 (en) | 2010-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN06053A1 (en) | 6-substituted anilino purines as rtk inhibitors | |
| NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
| NO20063422L (no) | Spirosyklisk sykloheksanderivater med affinitet for ORL1-reseptoren | |
| DE602005009745D1 (de) | Glucopyranosyl-substituierte benzen-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür | |
| BR0314393A (pt) | Piperazinas heterocìclicas substituìdas para o tratamento de esquizofrenia | |
| NO20064201L (no) | Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling | |
| NO20093060L (no) | Spirosykliske sykloheksanderivater | |
| ATE365742T1 (de) | 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren | |
| NO20044261L (no) | Indazoler substituerte med en anticanceros aktivitet | |
| MA28753B1 (fr) | Derives cycliques d'uree substitues par un heterocycle, leur preparation et leur utilisation pharmaceutique en tant qu'inhibiteurs de kinases | |
| NO20082939L (no) | Sykloheksyl piperasinyl metanon derivater og anvendelse av disse som histamin H3 reseptor modulatorer | |
| NO20084489L (no) | Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet | |
| WO2005033073A3 (en) | Spirocyclic heterocyclic derivatives and methods of their use | |
| ATE469151T1 (de) | Pyrrolopyridinderivate als proteinkinaseinhibitoren | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| ATE313532T1 (de) | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen | |
| GEP20125538B (en) | 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous system diseases | |
| MY144132A (en) | Polymorph forms of (2s)-(4e)-n-methyl-5-[3-(5-isoproproxypyridin)yl]-4-penten-2-amine | |
| NO20060871L (no) | Azepinderivater som farmasoytiske midler | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| BRPI0418255A (pt) | derivados de piperazina e piperidina n-substituìdos | |
| NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
| WO2007118151A3 (en) | Spirocyclic heterocyclic derivatives and methods of their use | |
| NO20054763L (no) | Salter av clopidogrel og fremgangsmate for fremstilling derav | |
| NO20055766L (no) | Positive modulatorer av nikotinacetylcholinreseptorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |